Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis-Reference-Cited by-同舟云学术

Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis

Published:2019-12-16 Issue:6 Volume:34 Page:1689-1693
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Adrianzen Herrera Diego,Pradhan Kith,Snyder Rose,Karanth Siddharth,Janakiram Murali^ORCID,Mantzaris Ioannis,Braunschweig Ira,Budhathoki Anjali,Shah Urvi A.,Verma Amit K.^ORCID,Murthy Santosh B.,Shastri Aditi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0673-8.pdf

Reference15 articles.

1. Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488–98.

2. Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111–21.

3. Libby P, Sidlow R, Lin AE, Gupta D, Jones LW, Moslehi J, et al. Clonal hematopoiesis: crossroads of aging, cardiovascular disease, and cancer: JACC review topic of the week. J Am Coll Cardiol. 2019;74:567–77.

4. Naqvi K, Sasaki K, Montalban-Bravo G, Alfonso Pierola A, Yilmaz M, Short N, et al. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome. Cancer. 2019. https://doi.org/10.1002/cncr.32056.

5. Brunner AM, Blonquist TM, Hobbs GS, Amrein PC, Neuberg DS, Steensma DP, et al. Risk and timing of cardiovascular death among patients with myelodysplastic syndromes. Blood Adv. 2017;1:2032–40.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular risk in elderly Egyptians with myelodysplastic syndromes;The Egyptian Journal of Internal Medicine;2024-01-31

2. Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis;Blood Advances;2023-11-16

3. Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes;Blood Advances;2023-06-30

4. Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes;Current Treatment Options in Oncology;2023-03-25

5. Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry;British Journal of Haematology;2022-11-06